# A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

> **NCT02036281** · PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 23 (actual)

## Conditions studied

- Terminally Ill
- Histologically-confirmed Advanced Cancer
- Pain, Intractable

## Interventions

- **DRUG:** Substance P-Saporin

## Key facts

- **NCT ID:** NCT02036281
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-09-28
- **Final completion:** 2016-09-28
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036281, "A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02036281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*